⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metastatic malignancy

Every month we try and update this database with for metastatic malignancy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial CarcinomaNCT05394337
Metastatic Mali...
Atezolizumab
Tiragolumab
18 Years - M.D. Anderson Cancer Center
Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial CarcinomaNCT05394337
Metastatic Mali...
Atezolizumab
Tiragolumab
18 Years - M.D. Anderson Cancer Center
Yield of Cryoprobe vs Flexible Forceps Pleural BiopsyNCT02500277
Pleural Effusio...
Pleurisy
Tuberculosis
Metastatic Mali...
Cryoprobe pleur...
Flexible forcep...
12 Years - 79 YearsPGIMER
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway AberrationsNCT02747797
Advanced Cancer
Lucitanib
18 Years - University of California, San Diego
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: